| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.7 | 0.008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.01 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |